Prosecution Insights
Last updated: April 19, 2026

BIOVERATIV THERAPEUTICS INC.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
4
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18358601 THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF BEANE, RANDALL L 1654 Final Rejection Jul 25, 2023
17821356 CLOSED-END DNA PRODUCTION WITH INVERTED TERMINAL REPEAT SEQUENCES GROOMS, TIFFANY NICOLE 1637 Final Rejection Aug 22, 2022
17821359 OPTIMIZED FACTOR VIII GENES DACE DENITO, ALEXANDRA GERALDINE 1636 Final Rejection Aug 22, 2022
17576562 ENGINEERED ITR SEQUENCES AND METHODS OF USE SHUKLA, RAM R 1635 Non-Final OA Jan 14, 2022
16965895 USE OF LENTIVIRAL VECTORS EXPRESSING FACTOR VIII MARVICH, MARIA 1634 Final Rejection Jul 29, 2020

Managing BIOVERATIV THERAPEUTICS INC.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month